Cathay International Holdings Ld Result of Special General Meeting (0404W)

TIDMCTI

RNS Number : 0404W

Cathay International Holdings Ld

12 April 2019

Cathay International Holdings Limited

("Cathay" or the "Company")

Result of Special General Meeting ("SGM")

Hong Kong, 12 April 2019 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China, today announces that at the SGM held earlier today, the Resolution as set out in the Notice of SGM dated 27 March 2019 was duly passed. The final poll voting result for the Resolution is shown in the table below. In accordance with the UK Listing Rules, only the votes attached to the listed Common Shares were counted for the purposes of voting on the Resolution.

 
        Ordinary resolution              For       Against   Total votes   Withheld 
  THAT: 
   The Further Disposal on 
   the terms set out and 
   defined in the Circular 
   is hereby approved, and 
   the Board or any duly 
   authorised committee thereof 
   is authorised to: 
   (i) make or agree any 
   amendment, variation, 
   waiver or extension to 
   the terms of the Further 
   Disposal, which is not 
   material; and 
   (ii) do all such other 
   things as the Board or 
   such committee may consider 
   necessary or desirable 
   in connection with the 
   Further Disposal (provided 
   that such other things 
   have no material impact 
   on the terms of the Further 
   Disposal), in each case 
   which the Board or such 
   committee considers reasonable 
   and in the best interests 
   of Shareholders as a whole.       272,722,215     3,321   272,725,536      3,088 
                                    ------------  --------  ------------  --------- 
 

Notes:

1. Any proxy votes which are at the discretion of the Chairman have been included in the 'For' total.

2. A vote 'Withheld' is not a vote in law and is not counted in the calculation of the proportion of the votes for and against the resolution.

A copy of the resolution passed at the meeting is being uploaded today to the National Storage Mechanism and will shortly be available for viewing at www.morningstar.com.

The final voting result for the resolution will also be displayed on the Company website at www.cathay-intl.com.hk

- ENDS -

For further enquiries, please contact:

 
 Cathay International Holdings Limited 
  Eric Siu (Finance Director)                    Tel: [phone] 
  Patrick Sung (Director and Controller) 
 Consilium Strategic Communications 
  Mary-Jane Elliott / Matthew Neal / Lindsey     Tel: [phone] 
  Neville                                        5702 
 

About Cathay

Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and an operator and investor in the healthcare sector in the People's Republic of China (the "PRC"). The Company and its subsidiaries (collectively the "Group") aim to leverage on investment opportunities in the growing domestic demand for high quality healthcare products in the PRC and build portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a track record of identifying investment opportunities in this area including: Lansen, a PRC specialty pharmaceutical company focused on rheumatology and dermatology; Haizi, a PRC inositol manufacturer; Natural Dailyhealth, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.

The Group employs approximately 1,800 people across the PRC, including over 20 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment in Shenzhen. For more information please visit the Company's website: http://www.cathay-intl.com.hk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

ROMITMPTMBJBMLL

(END) Dow Jones Newswires

April 12, 2019 04:42 ET (08:42 GMT)